{"nct_id":"NCT03151551","title":"A Study of Ixekizumab (LY2439821) Versus Adalimumab in Participants With Psoriatic Arthritis","status":"COMPLETED","status_verified_date":"2019-09","start_date":"2017-08-24","start_date_type":"ACTUAL","primary_completion_date":"2018-11-15","primary_completion_date_type":"ACTUAL","completion_date":"2019-09-04","completion_date_type":"ACTUAL","phases":["PHASE4"],"tickers":["LLY"]}